Find Grants for Municipalities, Political Subdivisions, and State Governments

Find out if you qualify for verified grants for Municipalities, Political Subdivisions, and State Governments . Discover your eligibility and key funding details for Municipalities, Political Subdivisions, and State Governments from major foundations and government agencies.

$ 100 Trillion
Total Dollars Available

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

Deadline: November 15, 2027

Opportunity Number: PAR-25-336

Agency: National Institutes of Health

Open Date: December 16, 2024

Close Date: November 15, 2027

Status: Posted

CFDA Numbers: 93.395

View Grant

Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)

Deadline: September 25, 2026

Opportunity Number: PAR-25-247

Agency: National Institutes of Health

Open Date: December 13, 2024

Close Date: September 25, 2026

Status: Posted

CFDA Numbers: 93.866

View Grant

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Deadline: September 10, 2027

Opportunity Number: PAR-25-325

Agency: National Institutes of Health

Open Date: December 13, 2024

Close Date: September 10, 2027

Status: Posted

CFDA Numbers: 93.393

View Grant

Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)

Deadline: May 8, 2027

Opportunity Number: PAR-25-317

Agency: National Institutes of Health

Open Date: December 13, 2024

Close Date: May 8, 2027

Status: Posted

CFDA Numbers: 93.313, 93.307, 93.399, 93.273, 93.310, 93.361

View Grant

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

Deadline: January 11, 2026

Opportunity Number: PAR-25-029

Agency: National Institutes of Health

Open Date: December 11, 2024

Close Date: January 11, 2026

Status: Posted

CFDA Numbers: 93.840, 93.838, 93.233, 93.837, 93.839

View Grant

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-346

Agency: National Institutes of Health

Open Date: December 11, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.394, 93.393, 93.121, 93.396, 93.395, 93.399

View Grant

HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)

Deadline: July 16, 2026

Opportunity Number: PAR-25-154

Agency: National Institutes of Health

Open Date: December 11, 2024

Close Date: July 16, 2026

Status: Posted

CFDA Numbers: 93.853, 93.846, 93.273, 93.865, 93.866, 93.121, 93.213, 93.279, 93.350

View Grant

High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)

Deadline: October 15, 2027

Opportunity Number: PAR-25-277

Agency: National Institutes of Health

Open Date: December 11, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.847

View Grant

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)

Deadline: October 19, 2026

Opportunity Number: PAR-25-155

Agency: National Institutes of Health

Open Date: December 11, 2024

Close Date: October 19, 2026

Status: Posted

CFDA Numbers: 93.350

View Grant

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

Deadline: January 11, 2026

Opportunity Number: PAR-25-028

Agency: National Institutes of Health

Open Date: December 11, 2024

Close Date: January 11, 2026

Status: Posted

CFDA Numbers: 93.838, 93.233, 93.839, 93.840, 93.837

View Grant

Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)

Deadline: June 18, 2026

Opportunity Number: PAR-25-157

Agency: National Institutes of Health

Open Date: December 10, 2024

Close Date: June 18, 2026

Status: Posted

CFDA Numbers: 93.350

View Grant

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Deadline: January 7, 2028

Opportunity Number: PAR-25-321

Agency: National Institutes of Health

Open Date: December 10, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.394, 93.395, 93.393, 93.399, 93.396

View Grant

BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)

Deadline: June 15, 2026

Opportunity Number: RFA-EY-25-001

Agency: National Institutes of Health

Open Date: December 9, 2024

Close Date: June 15, 2026

Status: Posted

CFDA Numbers: 93.173, 93.286, 93.213, 93.865, 93.866, 93.853, 93.867, 93.273, 93.242, 93.279

View Grant

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Deadline: November 2, 2026

Opportunity Number: PAR-24-280

Agency: National Institutes of Health

Open Date: December 9, 2024

Close Date: November 2, 2026

Status: Posted

CFDA Numbers: 93.846

View Grant

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

Deadline: November 2, 2026

Opportunity Number: PAR-24-279

Agency: National Institutes of Health

Open Date: December 9, 2024

Close Date: November 2, 2026

Status: Posted

CFDA Numbers: 93.846

View Grant

NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Deadline: March 4, 2027

Opportunity Number: PAR-25-141

Agency: National Institutes of Health

Open Date: December 9, 2024

Close Date: March 4, 2027

Status: Posted

CFDA Numbers: 93.846

View Grant

Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-330

Agency: National Institutes of Health

Open Date: December 9, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.847, 93.242, 93.855, 93.865

View Grant

Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)

Deadline: September 7, 2027

Opportunity Number: PAR-24-330

Agency: National Institutes of Health

Open Date: December 6, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.838, 93.839, 93.273, 93.866, 93.853, 93.361, 93.399, 93.837, 93.840, 93.233, 93.307

View Grant

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

Deadline: May 7, 2027

Opportunity Number: PAR-25-100

Agency: National Institutes of Health

Open Date: December 6, 2024

Close Date: May 7, 2027

Status: Posted

CFDA Numbers: 93.279

View Grant

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Deadline: June 2, 2026

Opportunity Number: RFA-TR-25-002

Agency: National Institutes of Health

Open Date: December 6, 2024

Close Date: June 2, 2026

Status: Posted

CFDA Numbers: 93.350

View Grant

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

Deadline: December 3, 2027

Opportunity Number: RFA-DA-26-055

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: December 3, 2027

Status: Posted

CFDA Numbers: 93.273, 93.279

View Grant

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

Deadline: December 3, 2027

Opportunity Number: RFA-DA-26-056

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: December 3, 2027

Status: Posted

CFDA Numbers: 93.273, 93.279

View Grant

Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)

Deadline: January 7, 2028

Opportunity Number: PAR-25-299

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.273, 93.307, 93.399

View Grant

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

Deadline: January 7, 2027

Opportunity Number: PAR-25-025

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.838, 93.839, 93.233, 93.837

View Grant

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

Deadline: January 7, 2027

Opportunity Number: PAR-25-026

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.840, 93.233, 93.839, 93.837, 93.838

View Grant
Linkedin-in
  • Austin
  • Atlanta
  • Boston
  • Memphis
  • Washington D.C.
© Copyright. All Rights Reserved. GTC360, LLC
  • Privacy Policy
  • Terms and Conditions
×

Request Grant Writing Assistance from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.